Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.135 AUD -5.26% Market Closed
Market Cap: 39.4m AUD
Have any thoughts about
Next Science Ltd?
Write Note

Next Science Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Next Science Ltd
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Next Science Ltd
ASX:NXS
Total Equity
$12.8m
CAGR 3-Years
-12%
CAGR 5-Years
100%
CAGR 10-Years
N/A
Nanosonics Ltd
ASX:NAN
Total Equity
AU$182.2m
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
24%
Polynovo Ltd
ASX:PNV
Total Equity
AU$72.1m
CAGR 3-Years
48%
CAGR 5-Years
23%
CAGR 10-Years
24%
SDI Ltd
ASX:SDI
Total Equity
AU$94m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
6%
Anteris Technologies Ltd
ASX:AVR
Total Equity
AU$28.6m
CAGR 3-Years
128%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Ansell Ltd
ASX:ANN
Total Equity
$1.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
5%
No Stocks Found

Next Science Ltd
Glance View

Market Cap
39.4m AUD
Industry
Health Care

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

NXS Intrinsic Value
1.454 AUD
Undervaluation 91%
Intrinsic Value
Price

See Also

What is Next Science Ltd's Total Equity?
Total Equity
12.8m USD

Based on the financial report for Dec 31, 2023, Next Science Ltd's Total Equity amounts to 12.8m USD.

What is Next Science Ltd's Total Equity growth rate?
Total Equity CAGR 5Y
100%

Over the last year, the Total Equity growth was 60%. The average annual Total Equity growth rates for Next Science Ltd have been -12% over the past three years , 100% over the past five years .

Back to Top